… Donepezil (DPZ) is an acetylcholinesterase inhibitor used for the clinical treatment of mild
cognitive impairment… known that cholinesterase inhibitors exhibit some side-effects with …

… Donepezil hydrochloride, a well-known acetylcholine esterase inhibitor that has received …
of 5 mg daily donepezil in ameliorating post-COVID memory impairments as measured by the …

… taking a cholinesterase inhibitor. Donepezil is one of three cholinesterase inhibitors that is
… who had already been taking cholinesterase inhibitors were on donepezil, this drug was the …

… Donepezil is a reversible acetylcholinesterase inhibitor. … released in the cholinergic terminals
during learning memory. … daily consumption of donepezil reduced recognition impairment, …

… Donepezil, a new AChE inhibitor structurally … , donepezil, rivastigmine and galantamine)
were licensed to control the key symptoms of AD, namely memory, and cognitive impairment. …

… to release by the HPA axis, memory may become impaired. These same underlying …
impairments in memory performance due to cortisol release, and this may interact with ACh effects …

… mainly of cholinesterase inhibitors like donepezil [3], … have been developed to improve
impairments in the cholinergic … as promising new targets in AD and in learning memory [11, 12]. …

… breakdown of acetylcholine after its action on the post-synaptic neurons 8 . Donepezil and
rivastigmine … of cholinesterase inhibitors therapy in patients with cognitive dysfunction 16,17 . …

… replaced by intermittent ripple oscillations, memory impairment was not observed, while …
cholinesterase inhibitors (ChEIs) have greatly improved AD symptoms management. Donepezil…

… system and that effect, along with cholinesterase inhibition, would contribute to improving …
suggest that donepezil treatment could ameliorate learning and memory impairment in T2D …